Phase II Study Evaluating the Effect of Concomitant Ramucirumab on the Pharmacokinetics of Docetaxel in Patients with Advanced Solid Tumors | Zendy

AI Assistant Blog Pricing

Open Access

Phase II Study Evaluating the Effect of Concomitant Ramucirumab on the Pharmacokinetics of Docetaxel in Patients with Advanced Solid Tumors

Author(s) -

Mark N. Stein,

Laura Q.M. Chow

Publication year - 2016

Publication title -

clinical pharmacology and biopharmaceutics

Language(s) - English

Resource type - Journals

ISSN - 2167-065X

DOI - 10.4172/2167-065x.1000161

Subject(s) - ramucirumab , docetaxel , concomitant , pharmacokinetics , medicine , oncology , maximum tolerated dose , pharmacology , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.